6.93
-0.14
(-1.98%)
At close: January 10 at 4:00:01 PM EST
6.86
-0.07
(-0.96%)
After hours: 7:55:07 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-74,341.00
-64,365.00
-50,139.00
-45,824.00
-23,597.00
Investing Cash Flow
--
--
--
-297.00
--
Financing Cash Flow
251,982.00
21,848.00
59,051.00
98,824.00
96,704.00
End Cash Position
295,340.00
99,704.00
142,142.00
133,539.00
80,094.00
Interest Paid Supplemental Data
1,975.00
534.00
--
--
--
Issuance of Capital Stock
253,569.00
7,529.00
42,297.00
81,924.00
71,990.00
Issuance of Debt
10,000.00
15,000.00
--
--
--
Repayment of Debt
-170.00
-844.00
--
--
--
Free Cash Flow
-74,341.00
-64,365.00
-50,139.00
-45,824.00
-23,597.00
12/31/2020 - 11/15/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATAI Atai Life Sciences N.V.
1.5000
-7.41%
CYBN Cybin Inc.
8.89
-7.01%
CYBN.NE Cybin Inc.
12.85
-7.22%
SANA Sana Biotechnology, Inc.
3.6600
-14.88%
HOTH Hoth Therapeutics, Inc.
1.9000
0.00%
RXRX Recursion Pharmaceuticals, Inc.
6.88
-5.23%
VIR Vir Biotechnology, Inc.
12.10
-3.04%
ABSI Absci Corporation
2.8550
-11.34%
SILO Silo Pharma, Inc.
1.7700
+3.51%
VKTX Viking Therapeutics, Inc.
39.31
-3.18%